Related Experiment Videos
Complement C3 F and BF S allotypes are risk factors for Chagas disease cardiomyopathy
I J Messias-Reason1, L Urbanetz, C Pereira da Cunha
1Laboratório de Imunopatologia, Departamento de Patologia Médica e Serviço de Cardiologia, Departamento de Clínica Médica, Universidae Federal do Paraná, Curitiba, Brazil. imunopat@hc.ufpr.br
Insights
Genetic factors influence Chagas disease severity. The study identified complement C3F allele as a susceptibility marker for Chagas cardiomyopathy and BF S allotype as potentially protective against severe disease.
Area of Science:
- Immunogenetics
- Molecular Biology
- Infectious Diseases
Background:
- Chagas disease clinical presentation varies significantly, suggesting genetic factors influence pathogenesis.
- Previous research points to genetic susceptibility markers for Chagas cardiomyopathy.
- The complement system, particularly the alternative pathway, plays a role in host defense against Trypanosoma cruzi.
Purpose of the Study:
- To investigate the association between complement system allotypes (C3, BF, C4A, C4B, C2) and susceptibility to Chagas disease.
- To identify genetic markers associated with the development of Chagas cardiomyopathy.
- To explore the role of the complement alternative pathway in Trypanosoma cruzi infection.
Main Methods:
- Genotyping of complement C3, BF, C4A, C4B, and C2 polymorphisms in 100 Chagasic patients (cardiomyopathic and asymptomatic) and 100 healthy controls.
- Patients and controls were matched for ethnic and geographical origin.
- Statistical analysis to compare allele frequencies between groups.
Main Results:
- The C3F allele was significantly more frequent in patients with the cardiomyopathic form (CARD) compared to asymptomatic (IND) and healthy controls.
- The BF S allotype showed a negative association in CARD patients and the overall Chagasic group compared to controls, suggesting a protective role.
- No significant differences were found for other C3, BF, C4A, C4B, and C2 alleles.
Conclusions:
- The C3F allele is a potential genetic marker for susceptibility to Chagas cardiomyopathy.
- The BF S allotype may confer protection against severe Chagas cardiomyopathy.
- These findings highlight the importance of the complement alternative pathway in Chagas disease and identify potential genetic markers for disease progression.
Abstract:
The heterogeneity in the clinical expression of Chagas disease gives strong evidences for the involvement of genetic factors on its pathogenesis. Several studies have indicated different markers of genetic susceptibility to Chagas cardiomyopathy. In the present study, we present evidence of association between complement C3 and BF allotypes, and the susceptibility to Chagas disease and the development of cardiomyopathy. C3, BF, C4A, C4B and C2 polymorphism were determined in 100 seropositive Chagasic patients [cardiomyopathic (CARD), n = 57; asymptomatic indetermined (IND), n = 43] and in 100 non-related seronegative healthy controls. Patients and controls were matched according to their ethnic and geographical origin. A significantly increased frequency of C3F was observed in patients with the CARD form (8/57 14.03%), when compared with those presenting the IND form (0/43, 0%; RR 7.0) and with the healthy controls (5/100, 5%; RR 3.1). A negative association of the BF S allotype was observed in the CARD patients (19/57 33.33%) and in the Chagas total (38/100 38.0%), when compared with the controls (55/100, 55.0%; RR 0.4). All other C3, BF, C4A, C4B and C2 alleles showed no significant differences. These results suggest the allele C3F as a susceptible marker for the progression of the CARD form. On the other hand, BF S may represent a protective role against severe CARD disease. These results corroborate the importance of the alternative pathway in Trypanosoma cruzi infection and indicate possible genetic markers of Chagas cardiomyopathy.